Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

HIMS Insider Trading

Hims & Hers Health, Inc. | Services-Offices & Clinics of Doctors of Medicine

Comprehensive Trading Performance Summary

The investment history of corporate insiders at Hims & Hers Health, Inc. provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Services-Offices & Clinics of Doctors of Medicine sector.

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2022-09-22 00:02 2022-09-20 O'Keefe Lynne Chou Director SELL $5.68 10,046 $57,061 0 -100.0%
2022-09-22 00:02 2022-09-20 Becklund Irene Officer - PAO SELL $5.68 10,668 $60,594 6,978 -60.5%
2022-09-12 23:39 2022-09-09 Becklund Irene Officer - PAO SELL $6.64 11,002 $73,053 2,715 -80.2%
2022-07-06 23:30 2022-07-05 Becklund Irene Officer - PAO SELL $5.00 19,331 $96,655 13,717 -58.5%
2022-06-23 01:07 2022-06-21 O'Keefe Lynne Chou Director SELL $4.35 10,045 $43,696 0 -100.0%
2022-06-16 23:41 2022-06-14 Maltz Jules A. Director, 10% owner BUY $3.66 75,000 $274,493 125,000 +150.0%
2022-06-09 23:23 2022-06-07 Maltz Jules A. Director, 10% owner BUY $3.99 50,000 $199,500 50,000 +100.0%
2022-05-23 23:04 2022-05-19 Okupe Oluyemi Officer - Chief Financial Officer BUY $3.52 7,500 $26,399 7,500 +100.0%
2022-03-18 23:02 2022-03-17 O'Keefe Lynne Chou Director SELL $4.50 10,044 $45,198 0 -100.0%
2022-03-04 00:09 2022-03-02 O'Keefe Lynne Chou Director SELL $5.04 40,178 $202,497 0 -100.0%
2022-03-03 00:46 2022-02-28 Carroll Patrick Harrison Director OPT+S $5.17 86,820 $448,859 123,719 0.0%
2022-03-03 00:44 2022-03-01 Becklund Irene Officer - PAO SELL $5.26 14,585 $76,644 11,002 -57.0%
2022-02-09 01:26 2022-01-20 Dudum Andrew Director, Officer, 10% owner - Chief Executive Officer BUY $5.17 1,500 $7,755 1,500 +100.0%
2022-02-09 01:26 2022-02-07 Boughton Soleil Officer - Chief Legal Officer SELL $4.41 24,516 $108,116 328,512 -6.9%
2022-02-08 01:05 2022-02-03 Boughton Soleil Officer - Chief Legal Officer SELL $4.50 49,032 $220,644 353,028 -12.2%
2021-12-17 05:23 2021-12-14 Abraham Jack 10% owner SELL $5.55 1,000,000 $5,548,300 7,171,203 -12.2%
2021-12-15 16:39 2021-12-13 Dudum Andrew Director, Officer, 10% owner - Chief Executive Officer BUY $5.93 81,100 $480,712 81,100 +100.0%
2021-08-30 16:16 2021-08-13 WELLS DAVID B Director BUY $8.24 360,000 $2,965,176 360,000 +100.0%
2021-08-04 04:40 2021-07-30 Institutional Venture Management XV, LLC 10% owner SELL $0.00 83,503 $0 10,201,746 -0.8%
2021-07-23 03:15 2021-05-24 Boughton Soleil Officer - Chief Legal Officer OPT+S $11.42 6,757 $77,136 379,537 0.0%
2021-07-23 03:14 2021-05-24 Carroll Patrick Harrison Officer - Chief Medical Officer OPT+S $11.08 3,938 $43,651 12,296 0.0%
2021-07-23 03:13 2021-05-24 Baird Melissa Officer - Chief Operating Officer OPT+S $10.91 41,076 $448,213 227,993 0.0%
2021-07-23 03:11 2021-05-24 Lee Spencer Officer - Chief Financial Officer OPT+S $10.92 57,752 $630,531 49,893 0.0%
2021-07-23 03:11 2021-05-24 Dudum Andrew Director, Officer, 10% owner - Chief Executive Officer OPT+S $10.71 218,695 $2,342,858 186,853 0.0%
SHOW ENTRIES

How to Interpret $HIMS Trades

Not every insider transaction in Hims & Hers Health, Inc. is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $HIMS shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for HIMS

Insider activity data for Hims & Hers Health, Inc. is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $HIMS, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.